Beernaert Hedwig, Vanherle Anne-Marie, Bertrand Sophie
Scientific Institute of Public Health, Bureau of Quality Assurance, Juliette Wytsmanstreet 14, 1050 Brussels, Belgium.
Ann Ist Super Sanita. 2008;44(4):348-56.
The Organisation for Economic Cooperation and Development (OEC D) principles of good laboratory practice (GLP) were originally developed for application to animal-based toxicology studies. On the other hand, more and more studies involving in vitro test systems are performed to produce data on the safety of chemicals with respect to human health and the environment. Therefore, national legislation usually requires that the in vitro studies are conducted in compliance with the GLP principles. Furthermore, developments in the area of toxicogenomics, toxicoproteomics, toxicometabonomics and various high throughput screening techniques will also enhance the importance of in vitro methodologies for safety testing. The OEC D principles of GLP require that safety studies, independent of their type, are planned, conducted, recorded, reported, and archived in a way that they can be inspected by the GLP monitoring authorities and scientifically evaluated by the receiving authorities. Some critical aspects and pitfalls are discussed as regards the proper application and interpretation of the GLP principles for the organisation and management of in vitro studies. Organisational charts and responsibilities of test facilities (TFs) involved in single or multisite studies are sometimes dysfunctioning because there is a lack of traceability in reporting and communication lines. Manipulation of cell and tissue cultures of different test systems should be separated and performed under aseptic conditions to prevent cross-contamination. Characterization and environmental conditions under which the test systems are manipulated and stored are critical in in vitro studies. Another important pitfall is the lack of description in the experimental design concerning the use of any internal control items to control bias and to evaluate the performance of the test system. Finally, it is observed that samples of long-term preservable test systems are not always retained or only for a short time which can lead to a lack of confirmation of test system identity and/or reconstructability of the study.
经济合作与发展组织(OECD)的良好实验室规范(GLP)原则最初是为应用于基于动物的毒理学研究而制定的。另一方面,越来越多涉及体外测试系统的研究被开展,以生成关于化学品对人类健康和环境安全性的数据。因此,国家立法通常要求体外研究要按照GLP原则进行。此外,毒理基因组学、毒理蛋白质组学、毒理代谢组学以及各种高通量筛选技术领域的发展,也将提升体外方法在安全性测试中的重要性。OECD的GLP原则要求,安全研究无论其类型如何,都应以这样一种方式进行规划、实施、记录、报告和存档,即它们能够被GLP监管机构检查,并由接收机构进行科学评估。关于在体外研究的组织和管理中正确应用和解释GLP原则,讨论了一些关键方面和陷阱。参与单站点或多站点研究的测试设施(TFs)的组织结构图和职责有时会出现功能失调,因为报告和沟通线路缺乏可追溯性。不同测试系统的细胞和组织培养操作应分开,并在无菌条件下进行,以防止交叉污染。测试系统的操作和储存所依据的特性及环境条件在体外研究中至关重要。另一个重要的陷阱是实验设计中缺乏关于使用任何内部对照项目以控制偏差和评估测试系统性能的描述。最后,观察到长期可保存测试系统的样本并非总是被保留,或者只保留很短时间,这可能导致缺乏对测试系统身份的确认和/或研究的可重构性。